NAV
$38.59
AUM
$69.1M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.95
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +10.09% | +3.67% | +8.84% | +16.58% | +13.71% | +7.29% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 5.45% |
| 2 | HSBA.L | HSBC Holdings PLC | 2.81% |
| 3 | AZN.L | AstraZeneca PLC | 2.44% |
| 4 | NOVN.SW | Novartis AG Registered Shares | 2.40% |
| 5 | CBA.AX | Commonwealth Bank of Australia | 1.73% |
| 6 | 9984.T | SoftBank Group Corp | 1.52% |
| 7 | TTE.PA | TotalEnergies SE | 1.50% |
| 8 | SU.PA | Schneider Electric SE | 1.50% |
| 9 | ALV.DE | Allianz SE | 1.47% |
| 10 | ABBN.SW | ABB Ltd | 1.46% |
The underlying index consists of large- and medium-capitalization companies across developed markets countries, excluding Canada and the United States. The fund will invest at least 80% of its total assets (but typically far more) in component securities (including depositary receipts in respect of such securities) of the underlying index. It is non-diversified.
Inception Date: 2018-09-05